Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of erenumab in chronic cluster headache
DRKS00025934Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cluster Headache (CH) comparing Erenumab with Placebo (2 arms). Started Aug 2021; status: completed.
02
Drugs
erenumab
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on DRKS00025934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00025934.